Clinical value of serum squamous cell carcinoma antigen in the management of sinonasal inverted papilloma

Head and Neck

Volumn 27, Issue 1, 2005, Pages 44-48

  Yasumatsu, Ryuji ^a,d   Nakashima, Torahiko ^a   Masuda, Muneyuki ^a   Kuratomi, Yuichiro ^a   Shiratsuchi, Hideki ^b   Hirakawa, Naoya ^b   Tomita, Kichinobu ^c   Yamamoto, Tomoya ^a   Komune, Shizuo ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^c NATIONAL KYUSHU CANCER CENTER   (Japan)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

Inverted papilloma; Sinonasal tract; Squamous cell carcinoma antigen; Tumor marker

Indexed keywords

SQUAMOUS CELL CARCINOMA ANTIGEN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INVERTED PAPILLOMA; MALE; PRIORITY JOURNAL; RECURRENCE RISK; SCHOOL CHILD; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, NEOPLASM; CARCINOMA, SQUAMOUS CELL; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMA, INVERTED; PARANASAL SINUS NEOPLASMS; REFERENCE VALUES; TUMOR MARKERS, BIOLOGICAL;

EID: 11144281200     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20115     Document Type: Article

References (20)

1. Myers EN, Fernau JL, Johnson JT, Tabet JC, Barnes EL. Management of inverted papilloma. Laryngoscope 1990; 100:481-490.
2. Krouse JH. Development of a staging system for inverted papilloma. Laryngoscope 2000;110:965-968.
3. Krouse JH. Endoscopic treatment of inverted papilloma: safety and efficacy. Am J Otolaryngol 2001;22:87-99.
4. Laniado ME, Lowdell C, Mitchell H, Christmas TJ. Squamous cell carcinoma antigen: a role in the early identification of nodal metastases in men with squamous cell carcinoma of the penis. BJU Int 2003;92: 248-250.
5. Ohno T, Nakayama Y, Nakamoto S, et al. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix. Cancer 2003;97:3114-3120.
6. Yasumatsu R, Nakashima T, Kuratomi Y, et al. Serum squamous cell carcinoma antigen is a useful biologic marker in patients with inverted papillomas of the sinonasal tract. Cancer 2002;94:152-158.
7. Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma. Cancer 1977; 40:1621-1628.
8. Schneider SS, Schick C, Fish KE, et al. A serine proteinase inhibitor locus at 18q21.3 contains a tandem duplication of the human squamous cell carcinoma antigen gene. Proc Natl Acad Sci U S A 1995;92:3147-3151.
9. Cataltepe S, Schick C, Luke CJ, et al. Development of specific monoclonal antibodies and a sensitive discriminatory immunoassay for the circulating tumor markers SCCA1 and SCCA2. Clin Chim Acta 2000;295:107-127.
10. Pradier O, Hille A, Schmiberger H, Hess CF. Monitoring of therapy in head and neck patients during the radiotherapy by measurement of Cyfra 21-1. Cancer Radiother 2002;6:15-21.
11. Esajas MD, Duk JM, de Bruijn HW, et al. Clinical value of routine serum squamous cell carcinoma antigen in follow-up of patients with early-stage cervical cancer. J Clin Oncol 2001;19:3960-3966.
12. Tabata T, Takeshima N, Tanaka N, Hirai Y, Hasumi K. Clinical value of tumor markers for early detection of recurrence in patients with cervical adenocarcinoma and adenosquamous carcinoma. Tumour Biol 2000;21: 375-380.
13. Numahara T, Nakashima K, Yamamoto S, Nishimoto M. Significance of squamous cell carcinoma-related antigen in psoriasis and generalized eczema. Preliminary report. Dermatologica 1989;178:73-74.
14. Suzuki K, Suzuki T, Akiyama J, et al. [Serum and pleural SCC-antigen levels in patients with pulmonary tuberculosis]. Kekkaku 1993;68:551-557.
15. Kulpa J, Wojcik E, Radkowski A, Kolodziejski L, Stasik Z. CYFRA 21-1, TPA-M, TPS, SCC-Ag and CEA in patients with squamous cell lung cancer and in chemical industry workers as a reference group. Anticancer Res 2000;20: 5035-5040.
16. Takeda M, Sakuragi N, Okamoto K, et al. Preoperative serum, SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix. Acta Obstet Gynecol Scand 2002;81:451-457.
17. Schmidt-Rhode P, Schulz KD, Sturm G, et al. Squamous cell carcinoma antigen for monitoring cervical cancer. Int J Biol Markers 1988;3:87-94.
18. Yen TC, Lin WY, Kao CH, Cheng KY, Wang SJ. A study of a new tumour marker, CYFRA 21-1, in squamous cell carcinoma of the head and neck, and comparison with squamous cell carcinoma antigen. Clin Otolaryngol 1998;23: 82-86.
19. Yasumatsu R, Nakashima T, Azuma K, et al. SCCA1 expression in T-lymphocytes peripheral to cancer cells is associated with the elevation of serum SCC antigen in squamous cell carcinoma of the tongue. Cancer Lett 2001; 167:205-213.
20. Savy L, Lloyd G, Lund VJ, Howard D. Optimum imaging for inverted papilloma. J Laryngol Otol 2000;114:891-893.